Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parasitic protozoa: thiol-based redox metabolism.

Rajeev K Mehlotra

    Trends in Parasitology
    |January 30, 2004
    PubMed
    Summary

    This study reviews the redox metabolism of parasitic protozoa, focusing on thiol-based enzymes like glutathione reductase and thioredoxin reductase. The authors suggest that these enzymes are vital for parasite survival and may serve as new drug targets. They compare parasite enzymes to host enzymes and find significant differences that could allow for selective drug action. The study does not claim these enzymes are essential for parasite survival but proposes they are promising candidates for drug development. The findings suggest that targeting these enzymes could disrupt parasite function without harming the host.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacogenomic variation in the Malagasy population: implications for the antimalarial drug primaquine metabolism.

    Pharmacogenomics·2023
    Same author

    <i>CYP2D6</i> gene resequencing in the Malagasy, a population at the crossroads between Asia and Africa: a pilot study.

    Pharmacogenomics·2022
    Same author

    <i>CYP2D6</i> Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar.

    Frontiers in pharmacology·2021
    Same author

    Chemokine receptor gene polymorphisms and COVID-19: Could knowledge gained from HIV/AIDS be important?

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2020
    Same author

    New Knowledge About CCR5, HIV Infection, and Disease Progression: Is "Old" Still Valuable?

    AIDS research and human retroviruses·2020
    Same author

    CCR5 Promoter Polymorphism -2459G > A: Forgotten or Ignored?

    Cells·2019

    Area of Science:

    • Parasitology within infectious disease research
    • Redox biology in protozoan metabolism
    • Drug discovery in parasitic diseases

    Background:

    Understanding the redox metabolism of parasitic organisms is a growing focus in parasitology. While much is known about the general redox systems in eukaryotic cells, less is understood about how these systems operate in parasitic protozoa. Prior research has shown that redox regulation is essential for cellular function and survival. However, the specific roles of thiol-based systems in parasites remain unclear. This gap motivated researchers to explore the unique redox pathways in protozoan parasites. No prior work had resolved how these pathways differ from host systems. That uncertainty drove the need for a focused review on thiol-based metabolism in parasitic protozoa. This paper addresses that need by summarizing current knowledge and identifying potential therapeutic targets.

    Purpose Of The Study:

    The aim of this study is to review the current understanding of thiol-based redox metabolism in parasitic protozoa. The researchers propose to examine the enzymes and pathways involved in this process. A specific problem is the lack of detailed information on how these systems function in parasites. This review seeks to clarify the roles of key enzymes in parasite survival. The motivation comes from the potential for these enzymes to serve as drug targets. This paper also aims to highlight the differences between parasite and host redox systems. By comparing these systems, the study may suggest new approaches for drug development. The authors believe that this work will contribute to the field of parasitic disease treatment.

    Keywords:
    parasitic protozoaredox enzymesdrug discoverythiol metabolism

    Frequently Asked Questions

    The main outcome is the identification of key enzymes like glutathione reductase and thioredoxin reductase as potential drug targets.

    These enzymes are crucial for parasite redox balance and differ from host enzymes, suggesting selective targeting may be possible.

    Glutathione reductase helps maintain redox balance by recycling oxidized glutathione in the parasite's cells.

    Parasite redox systems rely on distinct enzymes that are structurally and functionally different from host enzymes.

    Related Experiment Videos

    Main Methods:

    The authors conducted a literature review to analyze thiol-based redox metabolism in parasitic protozoa. They focused on enzymes such as glutathione reductase and thioredoxin reductase. The approach involved synthesizing findings from multiple studies on parasite redox systems. The researchers compared enzyme function across different protozoan species. They also examined how these enzymes interact with host redox systems. The review includes data on enzyme structure and function in parasites. The authors highlight the potential for these enzymes to serve as drug targets. This method allows for a comprehensive overview of current knowledge in the field.

    Main Results:

    The strongest finding is that thiol-based redox enzymes are crucial for parasite survival. The review identifies glutathione reductase as a key enzyme in maintaining redox balance. Thioredoxin reductase is also highlighted as a potential drug target. The authors suggest that these enzymes differ significantly from host enzymes. This difference may allow for selective drug targeting. The study also shows that parasite redox systems are distinct from those in mammalian cells. This distinction may explain why parasites are vulnerable to redox disruption. The findings propose that targeting these enzymes could lead to new antiparasitic drugs.

    Conclusions:

    The authors conclude that thiol-based redox metabolism is a promising area for drug development. They propose that key enzymes in this system may serve as effective drug targets. The review suggests that parasite-specific enzymes differ from host enzymes. This difference may allow for selective drug action. The authors believe that further research is needed to validate these enzymes as targets. They also suggest that understanding enzyme function could improve drug design. The study does not claim that these enzymes are essential for parasite survival. However, the findings suggest that targeting these enzymes may disrupt parasite function.

    Thioredoxin reductase is highlighted as a potential drug target due to its role in maintaining parasite redox homeostasis.

    The authors suggest that targeting thiol-based enzymes could lead to new antiparasitic drugs with reduced host toxicity.